ACOR Annual Total Assets
$108.53 M
-$287.07 M-72.57%
31 December 2023
Summary:
As of January 31, 2025, ACOR annual total assets is $108.53 million, with the most recent change of -$287.07 million (-72.57%) on December 31, 2023. During the last 3 years, it has fallen by -$524.15 million (-82.85%).ACOR Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Quarterly Total Assets
$81.58 M
-$26.95 M-24.83%
31 March 2024
Summary:
As of January 31, 2025, ACOR quarterly total assets is $81.58 million, with the most recent change of -$26.95 million (-24.83%) on March 31, 2024. Over the past year, it has dropped by -$293.33 million (-78.24%).ACOR Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.6% | -78.2% |
| 3 y3 years | -82.8% | -86.0% |
| 5 y5 years | -91.7% | -93.4% |
ACOR Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -91.9% | -93.9% |
Acorda Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $81.58 M(-24.8%) |
| Dec 2023 | $108.53 M(-72.6%) | $108.53 M(-70.4%) |
| Sept 2023 | - | $366.34 M(+0.5%) |
| June 2023 | - | $364.70 M(-2.7%) |
| Mar 2023 | - | $374.91 M(-5.2%) |
| Dec 2022 | $395.60 M(-13.1%) | $395.60 M(+0.6%) |
| Sept 2022 | - | $393.34 M(-3.2%) |
| June 2022 | - | $406.31 M(-4.2%) |
| Mar 2022 | - | $424.14 M(-6.9%) |
| Dec 2021 | $455.47 M(-28.0%) | $455.47 M(-2.3%) |
| Sept 2021 | - | $466.09 M(-5.2%) |
| June 2021 | - | $491.50 M(-15.8%) |
| Mar 2021 | - | $584.05 M(-7.7%) |
| Dec 2020 | $632.68 M(-20.9%) | $632.68 M(-10.9%) |
| Sept 2020 | - | $710.45 M(-2.4%) |
| June 2020 | - | $728.21 M(-3.4%) |
| Mar 2020 | - | $753.83 M(-5.7%) |
| Dec 2019 | $799.72 M(-38.5%) | $799.72 M(-9.1%) |
| Sept 2019 | - | $879.91 M(-26.5%) |
| June 2019 | - | $1.20 B(-3.0%) |
| Mar 2019 | - | $1.23 B(-5.1%) |
| Dec 2018 | $1.30 B(+8.5%) | $1.30 B(-0.9%) |
| Sept 2018 | - | $1.31 B(+4.8%) |
| June 2018 | - | $1.25 B(+5.4%) |
| Mar 2018 | - | $1.19 B(-0.9%) |
| Dec 2017 | $1.20 B(-10.8%) | $1.20 B(-10.9%) |
| Sept 2017 | - | $1.35 B(+0.9%) |
| June 2017 | - | $1.33 B(+1.0%) |
| Mar 2017 | - | $1.32 B(-1.7%) |
| Dec 2016 | $1.34 B(+20.8%) | $1.34 B(+1.8%) |
| Sept 2016 | - | $1.32 B(-2.1%) |
| June 2016 | - | $1.35 B(+11.1%) |
| Mar 2016 | - | $1.21 B(+9.0%) |
| Dec 2015 | $1.11 B(+4.3%) | $1.11 B(+1.0%) |
| Sept 2015 | - | $1.10 B(-0.0%) |
| June 2015 | - | $1.10 B(+0.1%) |
| Mar 2015 | - | $1.10 B(+3.2%) |
| Dec 2014 | $1.07 B | $1.07 B(+9.5%) |
| Sept 2014 | - | $972.77 M(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $943.32 M(+54.2%) |
| Mar 2014 | - | $611.89 M(+0.8%) |
| Dec 2013 | $607.13 M(+7.4%) | $607.13 M(+3.5%) |
| Sept 2013 | - | $586.65 M(+1.9%) |
| June 2013 | - | $575.91 M(+1.9%) |
| Mar 2013 | - | $565.42 M(+0.0%) |
| Dec 2012 | $565.33 M(+49.0%) | $565.33 M(+37.7%) |
| Sept 2012 | - | $410.45 M(+1.8%) |
| June 2012 | - | $403.05 M(+4.4%) |
| Mar 2012 | - | $386.05 M(+1.7%) |
| Dec 2011 | $379.49 M(+10.9%) | $379.49 M(+8.1%) |
| Sept 2011 | - | $351.10 M(+4.5%) |
| June 2011 | - | $336.10 M(-0.0%) |
| Mar 2011 | - | $336.21 M(-1.7%) |
| Dec 2010 | $342.10 M(+7.1%) | $342.10 M(+3.2%) |
| Sept 2010 | - | $331.42 M(+12.0%) |
| June 2010 | - | $295.99 M(-7.0%) |
| Mar 2010 | - | $318.22 M(-0.4%) |
| Dec 2009 | $319.47 M(+13.5%) | $319.47 M(-5.4%) |
| Sept 2009 | - | $337.60 M(-8.3%) |
| June 2009 | - | $368.17 M(+40.7%) |
| Mar 2009 | - | $261.67 M(-7.0%) |
| Dec 2008 | $281.50 M(+121.1%) | $281.50 M(-5.5%) |
| Sept 2008 | - | $297.98 M(+61.6%) |
| June 2008 | - | $184.40 M(-6.0%) |
| Mar 2008 | - | $196.13 M(+54.1%) |
| Dec 2007 | $127.31 M(+50.9%) | $127.31 M(-7.0%) |
| Sept 2007 | - | $136.86 M(+2.2%) |
| June 2007 | - | $133.91 M(+96.7%) |
| Mar 2007 | - | $68.09 M(-19.3%) |
| Dec 2006 | $84.37 M(+148.8%) | $84.37 M(+109.3%) |
| Sept 2006 | - | $40.32 M(-8.8%) |
| June 2006 | - | $44.19 M(-10.8%) |
| Mar 2006 | - | $49.55 M(+46.1%) |
| Dec 2005 | $33.91 M(+9.5%) | $33.91 M(+32.8%) |
| Sept 2005 | - | $25.54 M(-55.2%) |
| Dec 2004 | $30.98 M(-32.6%) | - |
| Dec 2003 | $45.96 M(-29.1%) | - |
| Sept 2003 | - | $57.02 M |
| June 2003 | $64.81 M | - |
FAQ
- What is Acorda Therapeutics annual total assets?
- What is the all time high annual total assets for Acorda Therapeutics?
- What is Acorda Therapeutics annual total assets year-on-year change?
- What is Acorda Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly total assets year-on-year change?
What is Acorda Therapeutics annual total assets?
The current annual total assets of ACOR is $108.53 M
What is the all time high annual total assets for Acorda Therapeutics?
Acorda Therapeutics all-time high annual total assets is $1.34 B
What is Acorda Therapeutics annual total assets year-on-year change?
Over the past year, ACOR annual total assets has changed by -$287.07 M (-72.57%)
What is Acorda Therapeutics quarterly total assets?
The current quarterly total assets of ACOR is $81.58 M
What is the all time high quarterly total assets for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly total assets is $1.35 B
What is Acorda Therapeutics quarterly total assets year-on-year change?
Over the past year, ACOR quarterly total assets has changed by -$293.33 M (-78.24%)